Literature DB >> 28108292

Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, β-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of Alzheimer's disease.

Jennifer M Walker1, Shilpy Dixit1, Anjelica C Saulsberry1, James M May1, Fiona E Harrison2.   

Abstract

This study assessed the extent to which high fat diet (HFD)-induced β-amyloid accumulation and cognitive decline in APP/PSEN1 mice are reversible through control of fat intake. Ten months of HFD (60% calories from fat) led to significant deficits in a 2-trial Y maze task, and nest building assay, and decreased voluntary locomotor activity. The HFD induced an inflammatory response, indicated by increased expression of several inflammatory markers. Substituting a low fat diet led to pronounced weight loss and correction of glucose intolerance, decreases in the inflammatory response, and improved performance on behavioral tasks in both wild-type and APP/PSEN1 transgenic mice. Insoluble β-amyloid levels, and extent of tau phosphorylation were also lower following dietary reversal in APP/PSEN1 mice compared to high fat-fed animals, indicating that the inflammatory response may have contributed to key pathogenic pathways in the Alzheimer's disease model. The data suggest that weight loss can be a vital strategy for cognitive protection, but also highlight potential mechanisms for intervention when sustained weight loss is not possible. Copyright Â
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behavior; Cognition; Inflammatory response, β-amyloid, high fat diet; Obesity

Mesh:

Substances:

Year:  2017        PMID: 28108292      PMCID: PMC5316363          DOI: 10.1016/j.nbd.2017.01.004

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  62 in total

1.  Geniposide Attenuates the Phosphorylation of Tau Protein in Cellular and Insulin-deficient APP/PS1 Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Yonglan Zhang; Fei Yin; Jianhui Liu; Zixuan Liu
Journal:  Chem Biol Drug Des       Date:  2015-11-12       Impact factor: 2.817

2.  Intravenous ascorbate improves spatial memory in middle-aged APP/PSEN1 and wild type mice.

Authors:  John A Kennard; Fiona E Harrison
Journal:  Behav Brain Res       Date:  2014-02-05       Impact factor: 3.332

Review 3.  Weight Loss Interventions in Older Adults with Obesity: A Systematic Review of Randomized Controlled Trials Since 2005.

Authors:  John A Batsis; Lydia E Gill; Rebecca K Masutani; Anna M Adachi-Mejia; Heather B Blunt; Pamela J Bagley; Francisco Lopez-Jimenez; Stephen J Bartels
Journal:  J Am Geriatr Soc       Date:  2016-09-19       Impact factor: 5.562

4.  Susceptibility to diet-induced obesity and glucose intolerance in the APP (SWE)/PSEN1 (A246E) mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein.

Authors:  N Mody; A Agouni; G D McIlroy; B Platt; M Delibegovic
Journal:  Diabetologia       Date:  2011-05-03       Impact factor: 10.122

5.  Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study.

Authors:  M F Elias; P K Elias; L M Sullivan; P A Wolf; R B D'Agostino
Journal:  Int J Obes Relat Metab Disord       Date:  2003-02

6.  2015 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2015-03       Impact factor: 21.566

Review 7.  Neurocognitive Effects of Obesity and Bariatric Surgery.

Authors:  Mary Beth Spitznagel; Misty Hawkins; Michael Alosco; Rachel Galioto; Sarah Garcia; Lindsay Miller; John Gunstad
Journal:  Eur Eat Disord Rev       Date:  2015-08-19

8.  Exercise is more effective than diet control in preventing high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice.

Authors:  Masato Maesako; Kengo Uemura; Masakazu Kubota; Akira Kuzuya; Kazuki Sasaki; Naoko Hayashida; Megumi Asada-Utsugi; Kiwamu Watanabe; Maiko Uemura; Takeshi Kihara; Ryosuke Takahashi; Shun Shimohama; Ayae Kinoshita
Journal:  J Biol Chem       Date:  2012-05-04       Impact factor: 5.157

Review 9.  Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

Authors:  Velandai Srikanth; Annette Maczurek; Thanh Phan; Megan Steele; Bernadette Westcott; Damian Juskiw; Gerald Münch
Journal:  Neurobiol Aging       Date:  2009-05-22       Impact factor: 4.673

10.  High Fat Diet Enhances β-Site Cleavage of Amyloid Precursor Protein (APP) via Promoting β-Site APP Cleaving Enzyme 1/Adaptor Protein 2/Clathrin Complex Formation.

Authors:  Masato Maesako; Maiko Uemura; Yoshitaka Tashiro; Kazuki Sasaki; Kiwamu Watanabe; Yasuha Noda; Karin Ueda; Megumi Asada-Utsugi; Masakazu Kubota; Katsuya Okawa; Masafumi Ihara; Shun Shimohama; Kengo Uemura; Ayae Kinoshita
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

View more
  29 in total

1.  Late Cognitive Consequences of Gestational Diabetes to the Offspring, in a New Mouse Model.

Authors:  Ricardo A L de Sousa; Emanuelle V de Lima; Tamara P da Silva; Renata V de Souza; Claudia P Figueiredo; Giselle F Passos; Julia R Clarke
Journal:  Mol Neurobiol       Date:  2019-05-21       Impact factor: 5.590

Review 2.  Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.

Authors:  Lijun Dai; Li Zou; Lanxia Meng; Guifen Qiang; Mingmin Yan; Zhentao Zhang
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

3.  Combination of Omega 3 and Coenzyme Q10 Exerts Neuroprotective Potential Against Hypercholesterolemia-Induced Alzheimer's-Like Disease in Rats.

Authors:  Ghadha Ibrahim Fouad
Journal:  Neurochem Res       Date:  2020-03-02       Impact factor: 3.996

Review 4.  Blood-Brain Barriers in Obesity.

Authors:  Elizabeth M Rhea; Therese S Salameh; Aric F Logsdon; Angela J Hanson; Michelle A Erickson; William A Banks
Journal:  AAPS J       Date:  2017-04-10       Impact factor: 4.009

5.  Circadian rhythm disruption with high-fat diet impairs glycemic control and bone quality.

Authors:  Joan E LLabre; Ruben Trujillo; Grażyna E Sroga; Mariana G Figueiro; Deepak Vashishth
Journal:  FASEB J       Date:  2021-09       Impact factor: 5.834

Review 6.  Microbiota impacts on chronic inflammation and metabolic syndrome - related cognitive dysfunction.

Authors:  María Arnoriaga-Rodríguez; José Manuel Fernández-Real
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

7.  Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents metabolic dysfunction and Alzheimer's disease-related memory loss in senescence-accelerated prone 8 (SAMP8) mice fed a high-fat diet.

Authors:  Yutaro Kobayashi; Hiroyuki Inagawa; Chie Kohchi; Kimiko Kazumura; Hiroshi Tsuchiya; Toshiyuki Miwa; Katsuichiro Okazaki; Gen-Ichiro Soma
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

8.  Gut inflammation triggers C/EBPβ/δ-secretase-dependent gut-to-brain propagation of Aβ and Tau fibrils in Alzheimer's disease.

Authors:  Chun Chen; Yunzhe Zhou; Hualong Wang; Ashfaqul Alam; Seong Su Kang; Eun Hee Ahn; Xia Liu; Jianping Jia; Keqiang Ye
Journal:  EMBO J       Date:  2021-07-14       Impact factor: 14.012

9.  Altered DNA repair; an early pathogenic pathway in Alzheimer's disease and obesity.

Authors:  Hao Yu; Fiona Edith Harrison; Fen Xia
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

Review 10.  Overweight and diabetes prevention: is a low-carbohydrate-high-fat diet recommendable?

Authors:  Fred Brouns
Journal:  Eur J Nutr       Date:  2018-03-14       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.